Literature DB >> 11754604

Phyllanemblinins A-F, new ellagitannins from Phyllanthus emblica.

Y J Zhang1, T Abe, T Tanaka, C R Yang, I Kouno.   

Abstract

Six new ellagitannins, phyllanemblinins A-F (1-6), were isolated from Phyllanthus emblica, along with 30 known tannins and related compounds. Their structures were determined by spectral and chemical methods. Phyllanemblinins A (1) and B (2) were confirmed to be ellagitannins having a tetrahydroxybenzofuran dicarboxyl group and a hexahydroxydiphenoyl group, respectively, by chemical synthesis from furosin (8). Phyllanemblinin C (3) has a new acyl group at the glucose 2,4-positions and is structurally related to chebulagic acid. Phyllanemblinins D (4), E (5), and F (6) were found to be positional isomers of neochebuloyl 1(beta)-O-galloylglucose.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754604     DOI: 10.1021/np010370g

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  12 in total

1.  Restorative effect of Kalpaamruthaa, an indigenous preparation, on oxidative damage in mammary gland mitochondrial fraction in experimental mammary carcinoma.

Authors:  Shanmugam Arulkumaran; Vanu Ramkumar Ramprasath; Palanivelu Shanthi; Panchanatham Sachdanandam
Journal:  Mol Cell Biochem       Date:  2006-09-05       Impact factor: 3.396

2.  Cytotoxic and natural killer cell stimulatory constituents of Phyllanthus songboiensis.

Authors:  Yulin Ren; Chunhua Yuan; Youcai Deng; Ragu Kanagasabai; Tran Ngoc Ninh; Vuong Tan Tu; Hee-Byung Chai; Djaja D Soejarto; James R Fuchs; Jack C Yalowich; Jianhua Yu; A Douglas Kinghorn
Journal:  Phytochemistry       Date:  2015-01-14       Impact factor: 4.072

3.  Novel strategies for upstream and downstream processing of tannin acyl hydrolase.

Authors:  Luis V Rodríguez-Durán; Blanca Valdivia-Urdiales; Juan C Contreras-Esquivel; Raúl Rodríguez-Herrera; Cristóbal N Aguilar
Journal:  Enzyme Res       Date:  2011-09-19

4.  Potential Antioxidant Role of Tridham in Managing Oxidative Stress against Aflatoxin-B(1)-Induced Experimental Hepatocellular Carcinoma.

Authors:  Vijaya Ravinayagam; Ravindran Jaganathan; Sachdanandam Panchanadham; Shanthi Palanivelu
Journal:  Int J Hepatol       Date:  2012-02-01

Review 5.  The Genus Phyllanthus: An Ethnopharmacological, Phytochemical, and Pharmacological Review.

Authors:  Xin Mao; Ling-Fang Wu; Hong-Ling Guo; Wen-Jing Chen; Ya-Ping Cui; Qi Qi; Shi Li; Wen-Yi Liang; Guang-Hui Yang; Yan-Yan Shao; Dan Zhu; Gai-Mei She; Yun You; Lan-Zhen Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-04-20       Impact factor: 2.629

Review 6.  Electrochemistry and Photoredox Catalysis: A Comparative Evaluation in Organic Synthesis.

Authors:  Rik H Verschueren; Wim M De Borggraeve
Journal:  Molecules       Date:  2019-06-05       Impact factor: 4.411

7.  Effects of 1,2,4,6-tetra-O-galloyl-β-D-glucose from P. emblica on HBsAg and HBeAg secretion in HepG2.2.15 cell culture.

Authors:  Yang-Fei Xiang; Huai-Qiang Ju; Shen Li; Ying-Jun Zhang; Chong-Ren Yang; Yi-Fei Wang
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

8.  Highly Oxygenated Limonoids and Lignans from Phyllanthus flexuosus.

Authors:  Jian-Qiang Zhao; Yan-Ming Wang; Hong-Tao Zhu; Dong Wang; Sheng-Hong Li; Rong-Rong Cheng; Chong-Ren Yang; Yi-Fei Wang; Min Xu; Ying-Jun Zhang
Journal:  Nat Prod Bioprospect       Date:  2014-07-22

9.  Enantiomeric Lignans and Neolignans from Phyllanthus glaucus: Enantioseparation and Their Absolute Configurations.

Authors:  Zhaodi Wu; Yongji Lai; Lei Zhou; Ye Wu; Hucheng Zhu; Zhengxi Hu; Jing Yang; Jinwen Zhang; Jianping Wang; Zengwei Luo; Yongbo Xue; Yonghui Zhang
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

10.  Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study.

Authors:  Mahendra Parkash Kapoor; Koji Suzuki; Timm Derek; Makoto Ozeki; Tsutomu Okubo
Journal:  Contemp Clin Trials Commun       Date:  2019-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.